BioLoomics

Boulder, United States

BioLoomics is a biotechnology company that develops antibodies for cancer therapies.

$8.7M raised

Sep 2023

Seed

Top Investors

Hummingbird VenturesInnovation EndeavorsTechU VenturesBoxOne VenturesBoom Capital Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioLoomics raised?

BioLoomics has raised $8.7M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are BioLoomics's investors?

BioLoomics's investors include Hummingbird Ventures, Innovation Endeavors, TechU Ventures, BoxOne Ventures, Boom Capital Ventures.

Where is BioLoomics headquartered?

BioLoomics is headquartered in Boulder, United States.

What does BioLoomics do?

BioLoomics is a biotechnology company that develops antibodies for cancer therapies.

What stage is BioLoomics at?

BioLoomics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 19, 2023.

MLA

"BioLoomics — Funding & Investors." VCBacked, September 19, 2023, https://www.vcbacked.co/company/bioloomics. Accessed June 4, 2026.

APA

VCBacked. (2023). BioLoomics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/bioloomics

Wikipedia (cite web)

{{cite web |title=BioLoomics — Funding & Investors |url=https://www.vcbacked.co/company/bioloomics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 19, 2023.